ASTA Follows Up with FDA on Saffron Holds and Rejections
ASTA Executive Director Laura Shumow met with U.S. Food and Drug Administration (FDA) officials regarding the increased inspection and detention of saffron shipments for economically motivated adulteration.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
ASTA Sends Letter to Indian Spices Board Following Recent EtO Scrutiny
Following recent reports of the Food Safety and Standards Authority of India’s (FSSAI) suspension of ethylene oxide (EtO) operations after several EtO-treated spices originating from India were recalled in Singapore and Hong Kong, ASTA sent a letter to the Indian Spices Board to offer information on EtO use and regulations for spices in the U.S.
FDA Extends Comment Period for Revised “Appendix 1” Draft Guidance
FDA extended the comment period for the revised Appendix 1: Known or Reasonably Foreseeable Hazards (“Potential Hazards”) of the Hazard Analysis and Risk-Based Preventive Controls for Human Food: Draft Guidance for Industry by 60 days.
